Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Lexapro Insomnia: Early Side Effect or Sign of Wrong Fit?

Clinically reviewed by Elizabeth Lokenauth, PA-C, CAQ-Psy

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • In Lexapro's FDA trials, insomnia affected 9% of adults treated for depression versus 4% on placebo, and 12% versus 6% in anxiety trials.
  • Insomnia is dose-related. In fixed-dose depression trials it rose from 7% at 10 mg to 14% at 20 mg, and 20 mg didn't outperform 10 mg for depression.
  • SSRI sleep effects are usually strongest in the first few weeks but can persist, so track your sleep rather than just waiting.
  • Timing is your best clue: insomnia that began with Lexapro or a dose increase points to the drug, while insomnia that came first may be depression.
  • Feeling energized on very little sleep, intense restlessness, or worsening mood needs prompt attention. Don't stop Lexapro suddenly.

It’s 3 a.m., you’ve been on Lexapro for ten days, and you’re wide awake again. Your days might feel a little calmer, but your nights feel worse than before you started. It’s fair to wonder whether this is a phase to push through or a sign that something about your treatment needs to change.

Lexapro (escitalopram) is thought to work by keeping more serotonin, one of your brain’s chemical messengers, active between nerve cells. A 2017 sleep review explains that SSRIs like Lexapro can disrupt sleep by activating certain serotonin receptors, delaying and suppressing REM sleep (the dreaming stage), and breaking up sleep continuity. Getting your dose and timing right takes precision, because the same change that steadies your mood can also keep your brain alert at night.

Lexapro’s track record is solid. Lexapro’s FDA label draws on placebo-controlled trials in more than 1,300 adults with depression and more than 850 with generalized anxiety disorder, and those same trials list insomnia among its most commonly observed side effects. The results are real, and the science is well established.

But “give it two weeks” only works if someone checks back to see whether the insomnia actually passed, and at Siggy we think sleep deserves the same attention as mood when you start an SSRI.

That means looking at when your insomnia started, what dose you’re on, and whether something more important is hiding behind those sleepless nights, because insomnia caused by the drug and insomnia caused by depression call for different treatment.

What This Page Covers

How Common Is Lexapro Insomnia?

It’s common enough that the label lists it first among Lexapro’s most commonly observed side effects. In the depression trials, 9% of adults taking Lexapro reported insomnia, compared with 4% on placebo. In the anxiety trials, it was 12% versus 6%, and abnormal dreams were slightly more common too, at 3% versus 2%.

Most people don’t quit over it. In the anxiety trials, insomnia led 1% of people to stop Lexapro. Dose matters, though. In two fixed-dose depression trials, insomnia affected 4% of people on placebo, 7% on 10 mg, and 14% on 20 mg. Our overview of Lexapro side effects covers the rest of that list.

Why Can Lexapro Keep You Awake?

The sleep review groups SSRIs with antidepressants that can disrupt sleep in the short term, unlike sedating antidepressants that tend to improve it quickly. In a 24-week sleep lab study of 138 outpatients with depression, people taking escitalopram took longer to reach REM sleep than those on a comparison antidepressant, and their number of complete sleep cycles went down.

That may help explain a frustrating pattern: you can spend enough hours in bed and still wake up unrefreshed. Lexapro can bring other sleep disruptors as well. The label’s post-marketing reports include restless legs, nightmares, and restlessness, and the sleep review notes that SSRIs can trigger or worsen restless legs syndrome and nighttime teeth grinding. If daytime sleepiness is part of your picture, our guide to Lexapro tiredness explains why both can happen at once.

When Does Lexapro Insomnia Start, and Does It Fade?

The first weeks are the main window. Lexapro reaches steady levels in your blood within about a week, according to the label, and for adults, dose increases are spaced at least a week apart. New insomnia that shows up right after starting or right after a dose increase fits the timing of a side effect.

The sleep review notes that antidepressant effects on sleep are strongest in the first few weeks of treatment, and that sleep complaints usually improve after a few weeks of effective treatment. In some people, though, the sleep disruption persists.

In a 2004 SSRI study of 401 patients, most side effects first appeared within the first 2 weeks, yet most patients still had those same side effects when interviewed about 3 months later. That study looked at SSRIs as a group, but it’s a good reason to track your sleep instead of simply waiting.

Is It Lexapro or Your Depression Keeping You Up?

The sleep review reports that 60% to 90% of people with major depression have insomnia complaints, depending on how severe the episode is. For most, sleep improves as mood improves, but not for everyone.

The clearest data comes from the STAR*D citalopram trial, which tested citalopram (Celexa), the drug Lexapro is derived from. Among 428 people whose depression improved by at least half without fully remitting, 79% still woke in the middle of the night. That symptom newly appeared during treatment in 51% of those who didn’t have it at the start, and it hung on in about 82% of those who did. The authors argue that telling these two patterns apart may help guide treatment.

Drawing on Lexapro’s FDA label and the research above, here’s how the timing of your sleep problems can point in different directions.

When It Showed Up What It May Point To What to Ask About
Before starting Lexapro Underlying condition, like depression Whether mood is fully treated
First 1 to 2 weeks Early side effect Timing, tracking, follow-up
After a dose increase Dose-related side effect Whether a lower dose works
Months in, mood better Lingering or treatment-emergent insomnia CBT-I, dose, or a switch
Little sleep, lots of energy Possible hypomania Urgent prescriber review

These patterns aren’t a diagnosis, and sometimes it’s both. A week or two of notes on bedtime, wake time, night wakings, dose timing, and any dose changes gives your prescriber a clear timeline.

Can Timing or a Dose Change Help?

Often it can. Lexapro’s label allows a once-daily dose in the morning or evening, with or without food, and the sleep review notes that antidepressant effects on sleep depend on dose, timing, and how long you’ve been taking the drug. If you take Lexapro at night, a morning dose is a simple change to ask about.

Keep expectations realistic, though. Lexapro’s half-life is 27 to 32 hours, so it stays in your system around the clock, and there’s little direct research comparing morning with evening doses for sleep.

Dose may matter more. The label’s fixed-dose trial found that 20 mg didn’t work better than 10 mg for depression, and 10% of people on 20 mg stopped because of side effects, compared with 4% on 10 mg. If you’re on 20 mg and sleeping poorly, ask whether a lower dose could keep the benefit. Our guide to how doctors decide on a Lexapro dose explains that reasoning.

What Helps Besides Changing the Medication?

The American Academy of Sleep Medicine’s 2021 insomnia guideline strongly recommends multicomponent cognitive behavioral therapy for insomnia (CBT-I) for chronic insomnia in adults. It suggests against using sleep hygiene tips as a stand-alone treatment.

CBT-I has been tested alongside escitalopram specifically. In a 2008 pilot trial of 30 adults with depression and insomnia, all taking escitalopram, 61.5% of those who added CBT-I reached depression remission, compared with 33.3% of those who added a control therapy. Insomnia remission was 50% versus 7.7%. The authors note that insomnia can slow response to depression treatment and raise the risk of relapse.

In a 2017 randomized trial of 107 adults with depression and insomnia, everyone reported sleeping better, but lab sleep tests showed that time spent awake improved only in the CBT-I groups and got worse in the group taking an antidepressant (escitalopram) with sleep hygiene advice. How you feel you slept and how you actually slept don’t always match.

As for sleep aids, the sleep review notes that adding a benzodiazepine early in SSRI treatment is common but carries a risk that you won’t be able to stop after 14 to 28 days. Check any supplement with your prescriber too, and our guide to Lexapro and melatonin covers what to know.

When Is Insomnia a Sign of the Wrong Fit?

Most Lexapro insomnia is something to work through with your prescriber. These patterns deserve faster attention.

  • Sleeping very little but feeling energized rather than tired. The label warns that antidepressants can trigger a manic or mixed episode in people with bipolar disorder and recommends screening before treatment starts. A bipolar sleep review reports that 66% to 99% of people in a manic state experience a reduced need for sleep.
  • Intense restlessness or agitation that makes it hard to sit still. The label’s post-marketing reports include agitation, restlessness, and akathisia. A 1998 SSRI review notes that SSRIs can occasionally cause akathisia and that avoiding rapid, unnecessary dose increases may lower the risk.
  • Worsening mood, hopelessness, or thoughts of self-harm. Lexapro’s boxed warning calls for close monitoring for these changes, especially in the first few months and after dose changes.
  • Insomnia that hasn’t eased after timing and dose changes and keeps wearing down your days. At that point, a switch is a fair conversation.

Whatever you decide, don’t stop Lexapro on your own. The label lists insomnia, irritability, and dizziness among the symptoms that can follow stopping, and it recommends a gradual reduction. Our guide to tapering off Lexapro explains why.

If you’re thinking about harming yourself, call or text 988, or call 911 in an emergency.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, and SSRIs like Lexapro are one option. Siggy’s free, anonymous intake asks for no name, email, or account, so you can be honest about how your sleep, mood, and side effects are going.

The intake gathers structured information about your symptoms, medications, and dose history, and it doesn’t diagnose you on its own. A licensed prescriber reviews your full intake before anything is prescribed or changed. You’ll get a downloadable summary you can keep or share with any clinician, including whoever prescribes your Lexapro now.

Siggy isn’t an emergency service. If you’re in crisis, call 911 or call or text 988. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

The Bottom Line on Lexapro Insomnia

Lexapro insomnia is common, often dose-related, and usually worst in the first few weeks, but it doesn’t always fade by itself. When it started is your best clue to whether it’s the medication or depression that hasn’t fully lifted. A morning dose, a lower dose, CBT-I, or a switch can all help, and feeling energized on very little sleep needs prompt attention. If anxiety is part of what keeps you up, our guide to anxiety and insomnia explains how the two feed each other.

Start Your Anonymous Intake

If you’re in crisis right now, call 911 or call or text 988 first. If sleepless nights on Lexapro have you wondering whether your treatment is the right fit, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever helps you next.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Is insomnia a common side effect of Lexapro?

Yes, it's one of the most common. In Lexapro's FDA depression trials, 9% of adults taking it reported insomnia compared with 4% on placebo. In the anxiety trials, it was 12% compared with 6%. Rates were higher at 20 mg than at 10 mg.

How long does Lexapro insomnia last?

Often it eases over the first few weeks, since antidepressant effects on sleep tend to be strongest early. It doesn't always fade, though. In a study of people starting SSRIs, most side effects began in the first 2 weeks and were still present about 3 months later. If your sleep isn't improving after the first few weeks, talk with your prescriber.

Should I take Lexapro in the morning if it keeps me awake?

It's a reasonable change to ask about. Lexapro's label allows a once-daily dose in the morning or evening, with or without food. There's little direct research comparing the two for sleep, and Lexapro stays in your system around the clock, so a dose change may matter more. Check with your prescriber before changing your routine.

Can I take a sleep aid while on Lexapro?

Ask your prescriber first, because some sleep aids and supplements interact with SSRIs or carry their own risks. A review of antidepressants and sleep notes that adding a benzodiazepine early in SSRI treatment carries a risk that you won't be able to stop after 2 to 4 weeks. The American Academy of Sleep Medicine strongly recommends cognitive behavioral therapy for insomnia (CBT-I) for chronic insomnia.

Does Lexapro insomnia mean it isn't working?

It doesn't have to. Insomnia is a known side effect that can appear even while Lexapro is helping your mood. It can also be leftover depression: in a large study of people who improved on citalopram, the drug Lexapro is derived from, 79% of those who didn't fully recover still woke in the middle of the night. Your prescriber can help sort out which it is.

Can stopping Lexapro cause insomnia?

Yes, it can. Lexapro's label lists insomnia among the symptoms that can follow stopping, especially stopping suddenly, along with dizziness, irritability, anxiety, and electric-shock sensations. The label recommends reducing the dose gradually whenever possible, so work with your prescriber on any plan to stop or switch.

Sources

  1. AbbVie Inc. LEXAPRO (escitalopram) tablets prescribing information (NDA 021323), revised October 2023. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov
  2. Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of antidepressants on sleep. Current Psychiatry Reports. 2017;19(9):63. doi:10.1007/s11920-017-0816-4
  3. Quera-Salva MA, Hajak G, Philip P, et al. Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients. International Clinical Psychopharmacology. 2011;26(5):252-262. doi:10.1097/YIC.0b013e328349b117
  4. Hu XH, Bull SA, Hunkeler EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. Journal of Clinical Psychiatry. 2004;65(7):959-965. doi:10.4088/jcp.v65n0712
  5. McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. Journal of Clinical Psychopharmacology. 2011;31(2):180-186. doi:10.1097/JCP.0b013e31820ebd2c
  6. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262. doi:10.5664/jcsm.8986
  7. Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-495. doi:10.1093/sleep/31.4.489
  8. Carney CE, Edinger JD, Kuchibhatla M, et al. Cognitive behavioral insomnia therapy for those with insomnia and depression: a randomized controlled clinical trial. Sleep. 2017;40(4):zsx019. doi:10.1093/sleep/zsx019
  9. Steardo L Jr, de Filippis R, Carbone EA, Segura-Garcia C, Verkhratsky A, De Fazio P. Sleep disturbance in bipolar disorder: neuroglia and circadian rhythms. Frontiers in Psychiatry. 2019;10:501. doi:10.3389/fpsyt.2019.00501
  10. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. Journal of Psychopharmacology. 1998;12(2):192-214. doi:10.1177/026988119801200212